| 1047T | Each additional 50 sq cm, or each additional 0.5% of body area of infants and children, or part thereof, for autologous heterogeneous skin-construct graft application. |
| 1048T | Autologous heterogeneous skin-construct graft application, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 50 sq cm or less. |
| 1049T | Autologous heterogeneous skin-construct graft application, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; each additional 50 sq cm or each additional 0.5% of body area. |
| 1051T | Removal of subcutaneous heart failure decompensation monitor; interrogation device evaluation, in person or remote, up to 30 days, insertable. |
| 1052T | Subcutaneous heart failure decompensation monitor, with physiologic parameter analysis, report generation, review, and interpretation. |
| 1053T | Heart failure decompensation monitor, with physiologic parameter analysis, report generation, review, and interpretation. |
| 81529 | Oncology cutaneous melanoma, mRNA gene expression profiling by real-time RT-PCR of 31 genes, formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence risk including sentinel lymph node metastasis likelihood. |
| 81535 | Oncology gynecologic, live tumor cell culture and chemotherapeutic response by DAPI stain and morphology, predictive algorithm reported as drug response score; first single drug or drug combination. |
| 81536 | Oncology gynecologic, live tumor cell culture and chemotherapeutic response by DAPI stain and morphology, predictive algorithm reported as drug response score; each additional single drug or drug combination. |
| 81540 | Oncology tumor of unknown origin, mRNA gene expression profiling by real-time RT-PCR of 92 genes to classify tumor into main cancer type and subtype, algorithm reported as probability of predicted cancer type and subtype. |